SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹10 Cr | ₹8.57 Cr | ₹7.09 Cr | ₹6.83 Cr | ₹6.40 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SAKAR HEALTHCARE ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹10 Cr |
Mar2023 | ₹8.57 Cr |
Mar2022 | ₹7.09 Cr |
Mar2021 | ₹6.83 Cr |
Mar2020 | ₹6.40 Cr |
How is Deferred Tax Assets / Liabilities of SAKAR HEALTHCARE Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹10 Cr | 16.94 | |
Mar2023 | ₹8.57 Cr | 20.87 | |
Mar2022 | ₹7.09 Cr | 3.88 | |
Mar2021 | ₹6.83 Cr | 6.75 | |
Mar2020 | ₹6.40 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of SAKAR HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAKAR HEALTHCARE | ₹658.7 Cr | -4.4% | 6.6% | -16.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
SAKAR HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAKAR HEALTHCARE | -4.4% |
6.6% |
-16.9% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses